gliotoxin has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asquith, CRM; Coles, SJ; Hilton, ST; Hofmann-Lehmann, R; Laitinen, T; Poso, A; Sil, BC; Tizzard, GJ | 1 |
| Al-Hatmi, AMS; Bertoldi, A; Biswas, P; Crespo, R; de Crignis, E; de Hoog, S; Havlicek, V; Kan, TW; Kang, J; Katsikis, PD; Lebbink, JHG; LeMasters, E; Mahmoudi, T; Mueller, YM; Najafzadeh, MJ; Ne, E; Palstra, RJ; Ptackova, R; Rokx, C; Roling, M; Skriba, A; Stoszko, M; Sulc, M; van Ijcken, W; Verbon, A | 1 |
2 other study(ies) available for gliotoxin and HIV Coinfection
| Article | Year |
|---|---|
Novel epidithiodiketopiperazines as anti-viral zinc ejectors of the Feline Immunodeficiency Virus (FIV) nucleocapsid protein as a model for HIV infection.
Topics: Animals; Cats; Disease Models, Animal; HIV Infections; Humans; Immunodeficiency Virus, Feline; Nucleocapsid Proteins; Piperazines | 2019 |
Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency.
Topics: Gliotoxin; HeLa Cells; HIV Infections; HIV-1; Humans; Positive Transcriptional Elongation Factor B; Ribonucleoproteins; Ribonucleoproteins, Small Nuclear; RNA-Binding Proteins; Transcription Factors | 2020 |